Correction: What Are the Benefits and Risks of Fitting Patients with Radiofrequency Identification Devices?

by Levine, Mark, Adida, Ben, Mandl, Kenneth, Kohane, Isaac, Halamka, John
Published 2008

What Are the Benefits and Risks of Fitting Patients with Radiofrequency Identification Devices

by Levine, Mark, Adida, Ben, Mandl, Kenneth, Kohane, Isaac, Halamka, John
Published 2007

The human sodium-dependent ascorbic acid transporters SLC23A1 and SLC23A2 do not mediate ascorbic acid release in the proximal renal epithelial cell

by Eck, Peter, Kwon, Oran, Chen, Shenglin, Mian, Omar, Levine, Mark
Published 2013

Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study

by Parpia, Sameer, Thabane, Lehana, Julian, Jim A, Whelan, Timothy J, Levine, Mark N
Published 2013

Bystander Responses to a Violent Incident in an Immersive Virtual Environment

by Slater, Mel, Rovira, Aitor, Southern, Richard, Swapp, David, Zhang, Jian J., Campbell, Claire, Levine, Mark
Published 2013

Low Red Blood Cell Vitamin C Concentrations Induce Red Blood Cell Fragility: A Link to Diabetes Via Glucose, Glucose Transporters, and Dehydroascorbic Acid

by Tu, Hongbin, Li, Hongyan, Wang, Yu, Niyyati, Mahtab, Wang, Yaohui, Leshin, Jonathan, Levine, Mark
Published 2015

Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer

by Parpia, Sameer, Julian, Jim A, Thabane, Lehana, Gu, Chushu, Whelan, Timothy J, Levine, Mark N
Published 2014

Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times

by Parpia, Sameer, Julian, Jim A, Gu, Chushu, Thabane, Lehana, Levine, Mark N
Published 2014

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG...

by Addison, Christina L., Pond, Gregory R., Cochrane, Brandy, Zhao, Huijun, Chia, Stephen K., Levine, Mark N., Clemons, Mark
Published 2015

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

by Monti, Daniel A., Mitchell, Edith, Bazzan, Anthony J., Littman, Susan, Zabrecky, George, Yeo, Charles J., Pillai, Madhaven V., Newberg, Andrew B., Deshmukh, Sandeep, Levine, Mark
Published 2012

A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials

by Spears, Melanie, Yousif, Fouad, Lyttle, Nicola, Boutros, Paul C., Munro, Alison F., Twelves, Chris, Pritchard, Kathleen I., Levine, Mark N., Shepherd, Lois, Bartlett, John MS.
Published 2015

Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol

by Schünemann, Holger J, Ventresca, Matthew, Crowther, Mark, Briel, Matthias, Zhou, Qi, Garcia, David, Lyman, Gary, Noble, Simon, Macbeth, Fergus, Griffiths, Gareth, DiNisio, Marcello, Iorio, Alfonso, Beyene, Joseph, Mbuagbaw, Lawrance, Neumann, Ignacio, Van Es, Nick, Brouwers, Melissa, Brozek, Jan, Guyatt, Gordon, Levine, Mark, Moll, Stephan, Santesso, Nancy, Streiff, Michael, Baldeh, Tejan, Florez, Ivan, Gurunlu Alma, Ozlem, Solh, Ziad, Ageno, Walter, Marcucci, Maura, Bozas, George, Zulian, Gilbert, Maraveyas, Anthony, Lebeau, Bernard, Buller, Harry, Evans, Jessica, McBane, Robert, Bleker, Suzanne, Pelzer, Uwe, Akl, Elie A
Published 2016